rs1799930
| Orientation | plus | 
| Stabilized | plus | 
| Geno | Mag | Summary | 
|---|---|---|
| (A;A) | 2.4 | Somewhat increased risk of hearing loss | 
| (A;G) | 1.7 | Possibly slightly increased risk of hearing loss | 
| (G;G) | 0 | Normal | 
| Reference | GRCh38 38.1/141 | 
| Chromosome | 8 | 
| Position | 18400593 | 
| Gene | NAT2 | 
| is a | snp | 
| is | mentioned by | 
| dbSNP | rs1799930 | 
| dbSNP (classic) | rs1799930 | 
| ClinGen | rs1799930 | 
| ebi | rs1799930 | 
| HLI | rs1799930 | 
| Exac | rs1799930 | 
| Gnomad | rs1799930 | 
| Varsome | rs1799930 | 
| LitVar | rs1799930 | 
| Map | rs1799930 | 
| PheGenI | rs1799930 | 
| Biobank | rs1799930 | 
| 1000 genomes | rs1799930 | 
| hgdp | rs1799930 | 
| ensembl | rs1799930 | 
| geneview | rs1799930 | 
| scholar | rs1799930 | 
| rs1799930 | |
| pharmgkb | rs1799930 | 
| gwascentral | rs1799930 | 
| openSNP | rs1799930 | 
| 23andMe | rs1799930 | 
| SNPshot | rs1799930 | 
| SNPdbe | rs1799930 | 
| MSV3d | rs1799930 | 
| GWAS Ctlg | rs1799930 | 
| GMAF | 0.2456 | 
| Max Magnitude | 2.4 | 
| ? | (A;A) (A;G) (G;G) | 28 | 
|---|---|---|
| 
 
 | ||
rs1799930 is a SNP in the NAT2 gene, potentially encoding a variant detoxifying protein known as an N-acetyltransferase, but which NAT2 variant depends on which other NAT2 SNPs were also inherited. See the discussion of the NAT2 gene for a more complete explanation. Also known as G590A.
The risk allele for this SNP is rs1799930(A).
A user has posted a question on the Discussion page for this SNP.
[PMID 17513527 ] In an age-related hearing impairment study of 2500+ Caucasians ranging in age from 53 to 67, those with the AA genotype for NAT2*6A had worse hearing compared with heterozygous or homozygous GG subjects (p=0.013).
] In an age-related hearing impairment study of 2500+ Caucasians ranging in age from 53 to 67, those with the AA genotype for NAT2*6A had worse hearing compared with heterozygous or homozygous GG subjects (p=0.013).
[PMID 25155015 ] No association between NAT2*6A and AHRI was found in a study of 265 elderly UK volunteers.
] No association between NAT2*6A and AHRI was found in a study of 265 elderly UK volunteers.
[PMID 20180013] Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women
[PMID 16369173] N-acetyltransferase 2 gene polymorphism and presbycusis.
[PMID 17513527 ] Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment.
] Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment.
[PMID 22092036 ] Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes
] Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes
| ClinVar | |
|---|---|
| Risk | Rs1799930(A;A) | 
| Alt | Rs1799930(A;A) | 
| Reference | Rs1799930(G;G) | 
| Significance | Drug-response | 
| Disease | Slow acetylator due to N-acetyltransferase enzyme variant ethambutol | 
| Variation | info | 
| Gene | NAT2 | 
| CLNDBN | Slow acetylator due to N-acetyltransferase enzyme variant ethambutol, isoniazid, pyrazinamide, and rifampin response - Toxicity/ADR, Metabolism/PK | 
| Reversed | 0 | 
| HGVS | NC_000008.10:g.18258103G>A | 
| CLNSRC | OMIM Allelic Variant | 
| CLNACC | RCV000000758.1, RCV000417141.1, | 
[PMID 14724163 ] Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.
] Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.
[PMID 16112301 ] NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
] NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
[PMID 16416399 ] Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.
] Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.
[PMID 16847422 ] Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
] Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
[PMID 17160896 ] Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants.
] Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants.
[PMID 17335581 ] Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus.
] Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus.
[PMID 18252219 ] A powerful and flexible multilocus association test for quantitative traits.
] A powerful and flexible multilocus association test for quantitative traits.
[PMID 18268115 ] Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk.
] Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk.
[PMID 18298806 ] Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years.
] Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years.
[PMID 18547414 ] Genotyping panel for assessing response to cancer chemotherapy.
] Genotyping panel for assessing response to cancer chemotherapy.
[PMID 18680467 ] Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.
] Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.
[PMID 18768514 ] Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.
] Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.
[PMID 18773084 ] Multiple advantageous amino acid variants in the NAT2 gene in human populations.
] Multiple advantageous amino acid variants in the NAT2 gene in human populations.
[PMID 18936436 ] Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994.
] Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994.
[PMID 18990750 ] Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.
] Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.
[PMID 19390575 ] Lung cancer susceptibility model based on age, family history and genetic variants.
] Lung cancer susceptibility model based on age, family history and genetic variants.
[PMID 19766908] Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley.
[PMID 20043821 ] Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data.
] Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data.
[PMID 21324488] Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer.
[PMID 22137356] An unlikely role for the NAT2 genotypes and haplotypes in the oral cancer of south Indians.
[PMID 22336957] Impact of population diversity on the prediction of 7-SNP NAT2 phenotypes using the tagSNP rs1495741 or paired SNPs.
[PMID 22970273 ] The Differential Effect of NAT2 Variant Alleles Permits Refinement in Phenotype Inference and Identifies a Very Slow Acetylation Genotype
] The Differential Effect of NAT2 Variant Alleles Permits Refinement in Phenotype Inference and Identifies a Very Slow Acetylation Genotype
[PMID 23175176 ] Variation in PAH-related DNA adduct levels among non-smokers: the role of multiple genetic polymorphisms and nucleotide excision repair phenotype.
] Variation in PAH-related DNA adduct levels among non-smokers: the role of multiple genetic polymorphisms and nucleotide excision repair phenotype.
[PMID 24928356] Synergism between the N-acetyltransferase 2 gene and oxidant exposure increases the risk of idiopathic male infertility
[PMID 25005845] N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males
[PMID 25017831] N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population
[PMID 25081676] N-Acetyltransferase 2 Gene Polymorphisms are Associated with Susceptibility to Cancer: a Meta-analysis
[PMID 26409796 ] N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population
] N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population
[PMID 26445549 ] Associations of polymorphisms in NAT2 gene with risk and metastasis of osteosarcoma in young Chinese population
] Associations of polymorphisms in NAT2 gene with risk and metastasis of osteosarcoma in young Chinese population
[PMID 29505746] Association of N-acetyltransferase-2 and glutathione S-transferase polymorphisms with idiopathic male infertility in Vietnam male subjects.
- Is a snp
- In dbSNP
- SNPs on chromosome 8
- Has genotype
- Has population
- Uses omim
- On chip 23andMe v1
- On chip 23andMe v2
- On chip 23andMe v3
- On chip 23andMe v4
- On chip 23andMe v5
- On chip Affy GenomeWide 6
- On chip Ancestry v2
- On chip FTDNA2
- On chip HumanOmni1Quad
- On chip Illumina Human 1M
- On chip Ancestry v2c
- On chip Ancestry v2d


